Loading...
XKRX
000230
Market cap95mUSD
Dec 05, Last price  
12,430.00KRW
1D
-3.12%
1Q
41.57%
Jan 2017
-46.88%
Name

Ildong Holdings Co Ltd

Chart & Performance

D1W1MN
XKRX:000230 chart
P/E
2.23
P/S
0.21
EPS
5,582.50
Div Yield, %
Shrs. gr., 5y
1.70%
Rev. gr., 5y
17.61%
Revenues
657.57b
+2.99%
344,579,017,000361,582,105,000376,934,397,000395,940,147,000347,159,849,000348,468,342,530362,781,056,260395,231,104,220417,517,499,000476,385,097,00040,771,268,80041,070,663,19047,050,030,690292,221,432,210596,468,913,500592,374,545,920675,539,717,330638,447,517,670657,566,886,000
Net income
63.04b
P
23,119,075,00022,625,593,00018,138,291,00032,846,979,00018,587,293,00027,299,215,00016,887,957,0906,484,818,69011,855,626,23020,979,404,630265,988,145,290651,618,700-3,719,365,090-39,954,887,980-31,271,398,450-134,695,952,280-194,503,503,700-59,586,796,59063,038,086,000
CFO
17.31b
P
36,595,211,00016,232,112,000-3,581,963,00049,931,842,00026,011,651,00051,077,885,45018,478,113,52015,648,015,49039,357,140,94056,110,513,91046,643,056,140-2,191,496,7806,233,383,83014,342,013,5908,241,940,680-30,544,994,020-74,588,719,470-57,770,878,10817,314,031,000
Dividend
Dec 27, 2023100 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It also engages in the research and manufacture of health foods and ingredients, as well as offers hyaluronic acid for use in drugs, medical devices, and cosmetics; and various medical devices for beauty, cosmetic-surgery, and antiaging applications. In addition, the company distributes medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products through online. Further, it offers beauty and cosmetic surgery services; and pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions, as well as engages in advertising business. The company was formerly known as Ildong Pharmaceutical Co., Ltd. and changed its name to Ildong Holdings Co., Ltd. in August 2016. Ildong Holdings Co., Ltd. was founded in 1941 and is based in Seoul, South Korea.
IPO date
Jun 28, 1975
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT